Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals

Antiviral Therapy

Volumn 10, Issue SUPPL. 2, 2005, Pages

  Gerschenson, Mariana ^a   Shiramizu, Bruce ^a   LiButti, Daniel E ^a   Shikuma, Cecilia M ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; MITOCHONDRIAL DNA; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADIPOSE TISSUE; ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIPODYSTROPHY; MALE; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL TOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; THIGH;

ADIPOSE TISSUE; ADULT; DNA, MITOCHONDRIAL; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SKIN;

EID: 24044496607     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Shevitz A, Wanke CA, Falutz J & Kotler DP. Clinical perspectives on HIV-associated lipodystrophy syndrome: an update. AIDS 2001; 15:1917-1930.
2. Schambelan M, Benson CA, Carr A, Currier JS, Dube MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG & Saag MS; International AIDS Society-USA. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. Journal of Acquired Immune Deficiency Syndromes 2002; 31:257-275.
3. Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, Gastaut JA & Touraine JL. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 1999; 13:1659-1667.
4. Mallal SA, John M, Moore CB, James IR & McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000; 14:1309-1316.
5. Heath KV, Hogg RS, Chan KJ, Harris M, Montessori V, O'Shaughnessy MV & Montanera JS. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database. AIDS 2001; 15:231-239.
6. Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ Jr, Rhodes PH, Wood KC & Holmberg SD; HIV Outpatient Study Investigators. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001; 15:1389-1398.
7. Galli M, Ridolfo AL, Adorni F, Gervasoni C, Ravasio L, Corsico L, Gianelli E, Piazza M, Vaccarezza M, d'Arminio Monforte A & Moroni M. Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. Journal of Acquired Immune Deficiency Syndromes 2002; 29:21-31.
8. Kopecky J, Rossmeisl M, Flachs P, Bardova K & Brauner P. Mitochondrial uncoupling and lipid metabolism in adipocytes. Biochemical Society Transactions 2001; 29:791-797.
9. Dagan T, Sable C, Bray J & Gerschenson M. Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence. Mitochondrion 2002; 1:397-412.
10. Lewis W, Day BJ & Copeland WC. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nature Reviews. Drug Discovery 2003; 2:812-822.
11. Gerschenson M & Brinkman K. Mitochondrial Dysfunction in AIDS and its treatment. Mitochondrion 2004; 4:763-767.
12. Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S & Shiramizu B. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 2001; 15:1801-1809.
13. Walker UA, Bickel M, Lutke Volksbeck SI, Ketelsen UP, Schofer H, Setzer B, Venhoff N, Rickerts V & Staszewski S. Evidence of nucleoside analogue reverse transcriptase inhibitor - associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 2002; 29:117-121.
14. Cherry CL, McArthur JC, Hoy JF & Wesselingh SL. Nucleoside analogues and neuropathy in the era of HAART. Journal of Clinical Virology 2003; 26:195-207.
15. McComsey GA, Paulsen DM, Lonergan JT, Hessenthaler SM, Hoppel CL, Williams VC, Fisher RL, Cherry CL, White-Owen C, Thompson KA, Ross ST, Hernandez JE & Ross LL. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 2005; 19:15-23.
16. Shoffner JM. Oxidative phosphorylation disease diagnosis. Seminars in Neurology 1999; 19:341-351.
17. Pinti M, Pedrazzi J, Benatti F, Sorrentino V, Nuzzo C, Cavazzuti V, Biswas P, Petrusca DN, Mussini C, De Rienzo B & Cossarizza A. Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR. FEBS Letters 1999; 458:209-214.
18. Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, Pinti M, Cossarizza A & Shikuma C. Brief report: placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. Journal of Acquired Immune Deficiency Syndromes 2003; 32:370-374.
19. Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B & Mallal S. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 2003; 17:1329-1338.
20. Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA & Mallal SA. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV+, HAART recipients. Antiviral Therapy 2003; 8:323-331.
21. Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M & Cooper DA; Mitochondrial Toxicity (MITOX) Study Group. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. Journal of the American Medical Association 2002; 288:207-215.
22. Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, Nakamura T & Iwamoto A. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. Journal of Medical Virology 2003; 70:497-505.
23. Vohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, Richard D, Hudson TJ & Tchernof A. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obesity Research 2004; 12:1217-1222.
24. Digby JE, Crowley VE, Sewter CP, Whitehead JP, Prins JB & O'Rahilly S. Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes. International Journal of Obesity & Related Metabolic Disorders 2000; 24:585-592.
25. Orel M, Lichnovska R, Gwozdziewiczova S, Zlamalova N, Klementa I, Merkunova A & Hrebicek J. Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiological Research 2004; 53:501-505.
26. Lowell BB & Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 2000; 404:652-660.